MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma

Publisher： Karger

E-ISSN： 1421-9778|36|4|1430-1439

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.36, Iss.4, 2015-07, pp. : 1430-1439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MiR-495 Promotes Senescence of Mesenchymal Stem Cells by Targeting Bmi-1

By  

Cellular Physiology and Biochemistry, Vol. 42, Iss. 2, 2017-06 ,pp. : 780-796

Karger

Access to resources Recommend Favorite

miR‐135a Inhibits Cancer Stem Cell‐Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression

By  

STEM CELLS, Vol. 33, Iss. 5, 2015-05 ,pp. : 1377-1389

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR-410 Down-Regulates the Expression of Interleukin-10 by Targeting STAT3 in the Pathogenesis of Systemic Lupus Erythematosus

By  

Cellular Physiology and Biochemistry, Vol. 39, Iss. 1, 2016-06 ,pp. : 303-315

Karger

Access to resources Recommend Favorite

miR‐212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells

By  

IUBMB LIFE, Vol. 67, Iss. 5, 2015-05 ,pp. : 380-394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC

By Ulivi Paola   Foschi Giovanni   Mengozzi Marta   Scarpi Emanuela   Silvestrini Rosella   Amadori Dino   Zoli Wainer  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 10332-10342

MDPI

Access to resources Recommend Favorite